Fidelity Investments’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136M Buy
3,241,612
+882,255
+37% +$34.2M 0.01% 1109
2026
Q1
$88.9M Buy
2,359,357
+2,357,539
+129,678% +$77M ﹤0.01% 1230
2025
Q4
$54.7K Buy
1,818
+1,568
+627% +$44.4K ﹤0.01% 4061
2025
Q3
$6.55K Buy
250
+133
+114% +$3.17K ﹤0.01% 4715
2025
Q2
$2.49K Sell
117
-28
-19% -$632 ﹤0.01% 4830
2025
Q1
$3.08K Buy
145
+144
+14,400% +$2.96K ﹤0.01% 4814
2024
Q4
$20 Buy
+1
New +$21 ﹤0.01% 5376

Other funds holding GRDN

Fidelity Investments's GRDN Position: Q2 2026 in Review

Fidelity Investments increased its Guardian Pharmacy Services (GRDN) stake by 37% in Q2 2026, buying an estimated $34.2M and bringing the position to 3,241,612 shares worth $136M. The position accounts for 0.01% of the portfolio, ranked #1109.

Fidelity Investments first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Fidelity Investments held 3,241,612 shares of Guardian Pharmacy Services worth $136M as of Q2 2026.
  • Fidelity Investments bought 882,255 Guardian Pharmacy Services shares in Q2 2026, an estimated $34.2M.
  • Guardian Pharmacy Services made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1109 holding.
  • Fidelity Investments first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.